The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis. [PDF]
BMC Endocr Disord, 2021 Zou Y +6 more
europepmc +1 more source
Transcriptional Regulation of the Human PRL-Releasing Peptide (PrRP) Receptor Gene by a Dopamine 2 Receptor Agonist: Cloning and Characterization of the Human PrRP Receptor Gene and Its Promoter Region [PDF]
, 2002 Atushi Ozawa
openalex +2 more sources
Impulse control and correlation to dopamine agonist serum concentrations in people with Parkinson's disease. [PDF]
J NeurolStaubo SC +12 more
europepmc +1 more source
Prolactin-Secreting Leiomyoma Causing Hyperprolactinaemia Unresponsive to Dopamine Agonist Therapy and Resolution following Myomectomy. [PDF]
Case Rep Endocrinol, 2021 Barry L, Pather S, Gargya A, Marren A.
europepmc +1 more source
The Selective mGlu5 Receptor Agonist CHPG Inhibits Quinpirole-Induced Turning in 6-Hydroxydopamine-Lesioned Rats and Modulates the Binding Characteristics of Dopamine D2 Receptors in the Rat Striatum Interactions with Adenosine A2a Receptors [PDF]
, 2001 Patrizia Popoli
openalex +1 more source
Sex-based disparities in dopamine agonist response in patients with restless legs syndrome. [PDF]
J Sleep ResMogavero MP +9 more
europepmc +1 more source
Effects of the dopamine D2 agonist, quinpirole, on time and number processing in rats [PDF]
, 2001 Angelo Santi, Romina Coppa, Lori E. Ross
openalex +1 more source
The Activation of p300 Enhances the Sensitivity of Pituitary Adenomas to Dopamine Agonist Treatment by Regulating the Transcription of DRD2. [PDF]
Int J Mol SciLi S +7 more
europepmc +1 more source
The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas. [PDF]
BMC Endocr Disord, 2021 Wang S +6 more
europepmc +1 more source
Ameliorating effect of dopamine D2 agonist on impairment of prepulse inhibition in aged rats.
, 1999 Taku Yamaguchi +2 more
openalex +1 more source